Keene & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$2.95M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$539K |
| 3 |
Newmont
NEM
|
+$169K |
| 4 |
Corteva
CTVA
|
+$112K |
| 5 |
ScottsMiracle-Gro
SMG
|
+$94.3K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$7.3M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.98M |
| 3 |
Organon & Co
OGN
|
+$682K |
| 4 |
B
Barrick Mining
B
|
+$402K |
| 5 |
Intel
INTC
|
+$345K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 19.63% |
| 2 | Technology | 17.16% |
| 3 | Healthcare | 15.25% |
| 4 | Industrials | 10.01% |
| 5 | Energy | 9.86% |
Similar funds
Keene & Associates's Q4 2023 Portfolio in Review
As of Q4 2023, Keene & Associates held 82 positions worth $120M, down 3.3% from $125M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Keene & Associates withdrew a net $8.35M in Q4 2023, closing 2 positions and reducing 33 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $1.98M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Keene & Associates opened a new position in Vanguard Short-Term Treasury ETF worth $544K.
- Keene & Associates's largest Q4 2023 buy was Vanguard Short-Term Treasury ETF: 9,322 shares worth $544K.
- Keene & Associates added most to Devon Energy in Q4 2023, an estimated $2.95M increase.
- Keene & Associates's biggest Q4 2023 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $7.3M.
- Keene & Associates fully exited Walgreens Boots Alliance in Q4 2023, selling an estimated $1.98M.
- Keene & Associates's ten largest holdings make up 32% of its $120M portfolio in Q4 2023.
- Keene & Associates opened 1 new position and closed 2 in Q4 2023.
- Keene & Associates's portfolio value fell 3.3% quarter-over-quarter to $120M.
Based on Keene & Associates's 13F filing for Q4 2023, filed 30 Jan 2024.